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Cancer mortality in French Polynesia between 1984 and 1992
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Summary A mortality study of French Polynesia in the period 1984-92, although limited by the small
population living close to the test sites and the high proportion of deaths attributed to ill-defined causes, found
no excess of cancer that could confidently be attributed to the 41 atmospheric test explosions in 1966-74. A
study of cancer incidence is planned.
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The French army carried out 41 atmospheric nuclear test
explosions on the atolls of Mururoa and Fangataufa in
French Polynesia, between 1966 and 1974 (Bouchez and
Lecomte, 1995). At this time no study about cancer mortality
in French Polynesia has been published.
French Polynesia is made up of five archipelagos: Iles du
Vent, Iles sous le Vent, Marquises, Australes and Tuamotu-
Gambier, including about 121 atolls or islands spread over a
surface area of 4 million km2. Only 4000 km2 of this area is
land. Mururoa and Fangataufa are situated in the Taumotu-
Gambier archipelago. French Polynesia is divided into 58
administrative areas called 'communes'. The census of 1988
enumerated 163 790 inhabitants born in French Polynesia, of
whom 85% resided in either the Iles du Vent or the Iles sous
le Vent, which are more than 1000 km away from Mururoa
and Fangataufa. The Tuamotu-Gambier archipelago is the
largest and the most sparsely populated archipelago: about
4000 natives are living in a 500 km zone around the two test
sites, which are about 100 km apart.
Since January 1984, the cause of each death has been
recorded on every island or atoll by a public health employee
(Direction de la Sante Publique, 1989). From the Institut
Territorial de la Statistique (ITSTAT), we obtained the
causes of death in each commune between 1984 and 1992,
coded according to the ninth revision of the International
Classification of Diseases (ICD-9). We also obtained the
census data of 1983 and 1988. We have excluded transient
workers from France, by restricting our study to individuals
born and living in French Polynesia. Populations at risk in
each commune were estimated from the census. We also
obtained from IARC (Parkin et al., 1992) the population size
and the number of deaths, by site of cancer, for each 5 year
age group, during the period 1983 to 1987 in the Maori
population of New Zealand, and in the Hawaiian native
population. These last two countries are located about
4500 km from Mururoa.
In French Polynesia, 25% of the death certificates from
1984 to 1992 reported a poorly specified or unspecified cause
(ICD-9 code: 780-799). This proportion was higher in
persons under age 5 (42%) or over age 74 (38%) than at
other ages (19%). It also varied widely between archipelagos,
from 20% in Iles du Vent to 62% in Tuamotu-Gambier. This
variation can be partly explained by the low qualification of
the public health staff on the small atolls. Within the
Tuamotu-Gambier, this percentage did not vary with the
distance from the nuclear sites: 60% in atolls less than
500 km from Mururoa, 72% in those from 500 to 1000 km,
and 56% in those more than 1000 km.
For the total population, 1219 deaths from cancer were
reported between 1984 and 1992, representing 15% of all
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deaths. Overall, cancer mortality rates appeared to be higher
in the Iles du Vent than in the other archipelagos, but the
very high proportion of poorly specified or unspecified cause
of death in the other archipelagos represents a major problem
in the interpretation of the findings.
Overall, cancermortalityamongFrenchPolynesianswas4to
17% lower than among Maoris and Hawaiians (Table I). These
differences were probably explained by the lower rate ofpoorly
specified orunspecifiedcausesofdeath amongHawaiians [0.8%
in 1991 (Hawaii State Department ofHealth, 1992)] and Maoris
[4% in 1992 (Ministry ofHealth, 1994)].
Thyroid cancer mortality was found to be higher among
Polynesians than among Maoris and Hawaiians, whose death
rates for 1984- 1987 were already among the highest published
by IARC (Parkin et al., 1992). However, thyroid cancer
incidence is known to be still higher in at least one population
not covered by this IARC publication than in Maoris and
Hawaiians, namely, another Pacific Island group, New
Caledonia, which is located more than 4500 km from
Mururoa (Ballivet et al., 1995). The five males and nine
females who died from thyroid cancer between 1984 and 1992
resided in the Iles du Vent or in the Iles sous le Vent at time of
death, i.e. more than 1000 km from Mururoa. All but one were
born on islands located more than 1000 km from Mururoa,
and one was born in the Tuamotu-Gambier, about 950 km
from Mururoa. They were born between 1902 and 1944 and
were, therefore, already aged 20 or more at the time ofthe first
atmospheric test. Based on the experience of the Chernobyl
accident in 1986 (Kazakov et al., 1992; Likhtarev et al., 1995)
and of the Marshall Islands, which were contaminated by the
Bravo nuclear test in 1954 (Hamilton et al., 1987), thyroid
cancer causedbymassive radioiodine falloutwould beexpected
in individuals irradiated during childhood and residing either
near the site or in clusters. Contamination by radioiodine from
working in nuclear installations is also an unlikely explanation
for our observations, since the excess is observedmainly among
women, and very few native women worked on these test sites.
The present analysis fails to show evidence of a generalised
excess of cancer mortality in French Polynesia. However, this
study is limited by the very small local population living less
than 500 km away from the nuclear sites (about 4000
individuals), and the high rate of unknown causes of death.
A cancer registry in French Polynesia has been in existence
since 1980, and we are planning to analyse these data. Our
results show that an incidence study is necessary, which
would be more powerful and more precise than the present
mortality study.
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Table I Total number of deaths, world standardised mortality rates and standardised mortality ratios (SMRs) relative to Maoris and
Hawaiians in French Polynesia between 1984 and 1992 by site of cancer
Males Females
Rate per ioooooa SMRb SMR Rate per 100000 SMR SMR
Cancer sites ICD-9 Deaths (95% CI) Maori Hawaii Deaths (95% CI) Maori Hawaii
Oral cavity 140-149 33 7.4 (4.8-10.0) 2.31** 1.78 8 1.9 (0.6-3.2) 4.16 0.62
Digestive tract 150-159 173 44.2 (37.4-51.0) 0.78* 0.1** 104 25.1 (20.2-30.0) 0.72* 0.88
Lung and bronchus 162 223 59.1 (51.2-67.1) 0.80* 0.77 87 21.7 (17.1-26.4) 0.56*** 0.68*
Breast 174-175 3 0.6 (0.0-1.3) - 2.16 132 29.8 (24.7-35.0) 1.17 1.01
Female reproductive 179-184 89 20.4 (16.1-24.7) 0.82 1.35
organs
Prostrates 185 27 8.6 (5.3-11.8) 0.41** 1.03
Bladder 188 15 4.9 (2.4-7.3) 1.89 1.85 4 1.0 (0.0-1.9) 0.64 0.51
Thyroid 193 5 1.2 (0.1-2.3) 1.41 1.72 9 2.1 (0.7-3.5) 2.48 8.83*
Ill-defined sites 195-199 55 14.7 (10.7-18.60) 0.97 1.02 40 9.3 (6.4-12.3) 1.27 1.04
Lymphoma and leukaemia 200-208 49 9.4 (6.5-12.3) 0.97 0.66* 36 8.2 (5.4-11.0) 0.96 0.77
Other sites 77 17.4 (13.3-21.5) 1.06 1.11 53 11.0 (7.9-14.1) 1.50 1.52
All sites 140-208 660 167 (154-181) 0.85** 0.84** 562 131 (120-142) 0.88* 0.96
aWorld standardised; bStandardisedmortality ratio (SMR). The SMRis theratio between thenumberofdeaths observedamongPolynesians and
the number of deaths expected if death rates by sex and 5 year age groups were equal to that observed in the reference population. *P<0.05;
**P<0.01, ***P<0.001.
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